These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30032294)

  • 1. A meta-analysis of randomized controlled trials to compare long-term clinical outcomes of bioabsorbable polymer and durable polymer drug-eluting stents.
    Mridha N; Subhaharan D; Niranjan S; Rashid MK; Psaltis P; Singh K
    Eur Heart J Qual Care Clin Outcomes; 2019 Apr; 5(2):105-113. PubMed ID: 30032294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year clinical efficacy and safety of contemporary thin-strut biodegradable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysis of 9 randomized controlled trials.
    Kobayashi T; Sotomi Y; Suzuki S; Suwannasom P; Nakatani S; Morino Y; Ako J; Kozuma K; Hirayama A; Sakata Y; Higuchi Y
    Cardiovasc Interv Ther; 2020 Jul; 35(3):250-258. PubMed ID: 31422529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents.
    El-Hayek G; Bangalore S; Casso Dominguez A; Devireddy C; Jaber W; Kumar G; Mavromatis K; Tamis-Holland J; Samady H
    JACC Cardiovasc Interv; 2017 Mar; 10(5):462-473. PubMed ID: 28279314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Outcomes of Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Durable Polymer Drug-Eluting Stents: a Meta-Analysis of Randomized Controlled Trials.
    Lou Y; Yu Y; Xi Z; Gao Y; Liu W; Nie X
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):557-566. PubMed ID: 31773343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable polymer drug-eluting stent vs. contemporary durable polymer drug-eluting stents in patients with diabetes: a meta-analysis of randomized controlled trials.
    Bavishi C; Chugh Y; Kimura T; Natsuaki M; Kaiser C; Gordon P; Aronow HD; Abbott JD
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):81-88. PubMed ID: 31228186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of biodegradable polymer sirolimus-eluting stents versus durable polymer drug-eluting stents: A meta-analysis of randomized trials.
    Yang Y; Lei J; Huang W; Lei H
    Int J Cardiol; 2016 Nov; 222():486-493. PubMed ID: 27505339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).
    Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; den Heijer P; van der Ent M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1215-1221. PubMed ID: 28579236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis.
    Lv J; Wu Y; Zhang X; Jing T; Zhang L; Tong S; Song Z; Wang M; Wang G; Chi L
    Eur J Med Res; 2015 Mar; 20(1):21. PubMed ID: 25889197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update.
    Lupi A; Gabrio Secco G; Rognoni A; Lazzero M; Fattori R; Sheiban I; Sante Bongo A; Bolognese L; Agostoni P; Porto I
    Catheter Cardiovasc Interv; 2014 May; 83(6):E193-206. PubMed ID: 24478247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5,834 patients.
    Lupi A; Rognoni A; Secco GG; Lazzero M; Nardi F; Fattori R; Bongo AS; Agostoni P; Sheiban I
    Eur J Prev Cardiol; 2014 Apr; 21(4):411-24. PubMed ID: 23152364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early vessel healing after implantation of biodegradable-polymer and durable-polymer drug-eluting stent: 3-month angioscopic evaluation of the RESTORE registry.
    Suzuki S; Sotomi Y; Kobayashi T; Hamanaka Y; Nakatani S; Shiojima I; Sakata Y; Hirayama A; Higuchi Y
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):973-980. PubMed ID: 30874980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents: A meta-analysis of randomized controlled trials.
    Sakurai R; Burazor I; Bonneau HN; Kaneda H
    Int J Cardiol; 2016 Nov; 223():1066-1071. PubMed ID: 27634137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.
    Zocca P; Kok MM; van der Heijden LC; Danse PW; Schotborgh CE; Scholte M; Hartmann M; Linssen GCM; Doggen CJM; von Birgelen C
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):567-576. PubMed ID: 30143879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A propensity score-matched comparison of biodegradable polymer vs second-generation durable polymer drug-eluting stents in a real-world population.
    Zhao YJ; Teng M; Khoo AL; Ananthakrishna R; Yeo TC; Lim BP; Loh JP; Chan MY
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29316284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the biodegradable polymer everolimus-eluting stent with contemporary drug-eluting stents: A systematic review and meta-analysis.
    Picard F; Pighi M; de Hemptinne Q; Airaksinen J; Vinco G; de Pommereau A; Biancari F; Varenne O
    Int J Cardiol; 2019 Mar; 278():51-56. PubMed ID: 30503189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents: A systematic review and meta-analysis of 12 randomized controlled trials.
    Bundhun PK; Pursun M; Huang F
    Medicine (Baltimore); 2017 Nov; 96(47):e8878. PubMed ID: 29382011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials.
    de Waha A; Stefanini GG; King LA; Byrne RA; Serruys PW; Kufner S; Meier B; Jüni P; Kastrati A; Windecker S
    Int J Cardiol; 2013 Oct; 168(6):5162-6. PubMed ID: 23993323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials.
    de Waha A; King LA; Stefanini GG; Byrne RA; Serruys PW; Meier B; Jüni P; Kastrati A; Windecker S
    EuroIntervention; 2015 Apr; 10(12):1425-31. PubMed ID: 24602961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.